相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients With BRAF V600 Mutation-Positive Solid Tumors
Cathrine L. Denton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Effects of Particle Size, Food, and Capsule Shell Composition on the Oral Bioavailability of Dabrafenib, a BRAF inhibitor, in Patients with BRAF Mutation-Positive Tumors
Daniele Ouellet et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions
Alastair J. King et al.
PLOS ONE (2013)
Metabolism and Disposition of Oral Dabrafenib in Cancer Patients: Proposed Participation of Aryl Nitrogen in Carbon-Carbon Bond Cleavage via Decarboxylation following Enzymatic Oxidation
David A. Bershas et al.
DRUG METABOLISM AND DISPOSITION (2013)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V. Long et al.
LANCET ONCOLOGY (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Age-Related Changes in Pharmacokinetics
Shaojun Shi et al.
CURRENT DRUG METABOLISM (2011)
Cytochrome P450 turnover: Regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2008)
Assessment of type I error rates for the statistical sub-model in NONMEM
U Wählby et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2002)
Assessment of actual significance levels for covariate effects in NONMEM
U Wählby et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check
Y Yano et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
